Rituximab Biosimilar to Be Developed by Spectrum and Viropro

Quick Links In the News Analysis & Insight Webinars App Notes   Online Exclusives More at GEN Subscriber Tools   GEN NEWS HIGHLIGHTS Wednesday, January 5, 2011 View email in a browser           Forward to a colleague Rituximab Biosimilar to Be Developed by Spectrum and Viropro Roche/Genentech's mAb therapeutic raked in $5.6 billion in 2009 sales, and patents start expiring in 2014. Beckman Coulter to Develop aNK Assay for Pivotal Trial of Transgene's NSCLC Drug French company projects that Phase IIb/III study with TG4010 will start later this year. DBV Raises $25.5M in Series C for Clinical-Stage Food Allergy Desensitization Technology DBV's Viaskin platform is already undergoing human testing in patients with peanut and milk allergies. SPONSORED LINK Make your Biomanufacturing voice heard! Support effective industry growth & planning. 8th Annual Biomanufacturing study benchmarks critical global trends: Budget, new technologies, capacity, outsourcing hiring, downstream, disposables, expression systems, cost cutting, quality, more. BioPlan Associates, Inc. FREE summary, plus donation to GAVI, or ACS Click Here! Receive FREE summary Merck KGaA Buys Chinese Cell Culture Media Firm Beijing Skywing for About $18.8M It is hoped that the new client base in China will provide promising opportunities for Merck Millipore. Omeros Gains Rights to Antifibrinolytic Agents Candidates were licensed from The Regents of the University of California. Thomson Reuters and ChemAxon Couple Offerings to Search and Visualize Chemical Patents Users can now research Markush structures using ChemAxon's JChem software platform. Cephalon to Evaluate ImmunGene's mAb-Cytokine Fusion Technology for Six Cancer Targets ImmunGene claims this platform efficiently targets cancer cells and reduces cytokine toxicity. Lilly to Use ArGEN-X Technology for mAb R&D The Simple Antibody platform will be utilized, and Lilly will supply targets. Lonza to Leverage IDBS' Data Management and Execution Solution Bioprocess Execution System will allow storing of data in context and more efficient sharing between groups. AstraZeneca Turns to Kinaxo to Study PTMs Related to an Oncology Program Kinaxo's Cellular Target Profiling technology combines mass spec and software capabilities. Almirall and Forest Project Mid-2011 Aclidinium Filing as Third Phase III COPD Trial Triumphs Firms also anticipate starting Phase III combination-therapy studies during second half of 2011. You can view more news broken down into over 90 categories and updated daily. Analysis & Insight 2010 in Review: Biotechnology Highlights Gene patenting and ESCs were back in the headlines along with breakthroughs in sequencing, syn bio, and other fields.     More A&Is Webinars Available on Demand. Original Broadcast Date - December 16, 2010 Simplifying Targeted Protein Quantification with Mass Spec: The SRM Atlas and Multiplexed MRM Protein Assays Sponsored by: Agilent Technologies In Case You Missed It: If you couldn't attend a previous webinar, be sure to check out our On-Demand Archives. Application Note Library Stability Testing an Antibody Therapeutic in Different Formulations Using Dynamic Multi-Mode Spectroscopy (DMS) Turbidometric Growth Curve Measurements and Liquid Evaporation Studies with a Microplate Photometer Mapping Protein Stability Using Automated CD Outstanding Sensitivity for Confident Label-Free Interaction Analysis Analysis of an O-linked Glycopeptide Using Multiple Stage Mass Spectrometry More App Notes Online Exclusives BLOGBIOTECH: Will FDA Bid Adieu to Auld Lang Syne and Open Up to New Drugs and Devices    More Blogs More at GEN GEN Subscriber Tools Subscription Center l Unsubscribe l Update Your Profile l About GEN IMPORTANT! Make sure you receive your chosen GEN e-Newsletters. Add update@genengnews.com to your Address Book or Safe Senders List. It's easy! Click HERE for instructions. Contact Us For: Advertising   Editorial   Business and Partnership Opportunities This email was sent by: Genetic Engineering & Biotechnology News 140 Huguenot St., New Rochelle, NY 10801, USA